Cargando…

Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial

PURPOSE: To compare the incidence of nausea, vomiting, and arterial hypotension between carbetocin and oxytocin to prevent haemorrhage after caesarean section (CS). METHODS: A randomized controlled trial in term pregnant women undergoing planned CS. Groups were randomized to carbetocin or oxytocin....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannaerts, D., Van der Veeken, L., Coppejans, H., Jacquemyn, Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816867/ https://www.ncbi.nlm.nih.gov/pubmed/29484209 http://dx.doi.org/10.1155/2018/1374150

Ejemplares similares

Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study)
por: van der Nelson, Helen, et al.
Publicado: (2019)

Current research on carbetocin and implications for prevention of postpartum haemorrhage
por: Theunissen, Fiona J., et al.
Publicado: (2018)

Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands
por: Holleboom, C. A. G., et al.
Publicado: (2013)

Carbetocin versus Oxytocin for the Prevention of Postpartum Hemorrhage in Cesarean Deliveries: A Retrospective Study of Two Consecutive Periods
por: Delorme, Pierre, et al.
Publicado: (2020)

Carbetocin vs oxytocin for prevention of postpartum hemorrhage after vaginal delivery: A meta-analysis
por: Jin, Xin-Hang, et al.
Publicado: (2019)

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
por: Rajaei, Minoo, et al.
Publicado: (2014)

Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
por: Gil-Rojas, Yaneth, et al.
Publicado: (2018)

Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial
por: Adnan, Nita, et al.
Publicado: (2017)

Room temperature stable carbetocin for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally: study protocol for a randomized controlled trial
por: Widmer, Mariana, et al.
Publicado: (2016)

How to use heat-stable carbetocin and tranexamic acid for the prevention and treatment of postpartum haemorrhage in low-resource settings
por: Tran, Nguyen Toan, et al.
Publicado: (2022)

Implementing Heat-Stable Carbetocin for Postpartum Haemorrhage Prevention in Low-Resource Settings: A Rapid Scoping Review
por: Tran, Nguyen Toan, et al.
Publicado: (2022)

Comparison of Oxytocin vs. Carbetocin Uterotonic Activity after Caesarean Delivery Assessed by Electrohysterography: A Randomised Trial
por: Paljk Likar, Ivana, et al.
Publicado: (2022)

Development and stability of a heat‐stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle‐income countries
por: Malm, Mattias, et al.
Publicado: (2018)

An explorative analysis of pharmacovigilance data of oxytocin and its analogue carbetocin, with a focus on haemodynamic adverse effects
por: Stämpfli, Dominik, et al.
Publicado: (2023)

Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial
por: Adnan, Nita, et al.
Publicado: (2018)

Efficacy and safety of carbetocin applied as an intravenous bolus compared to as a short-infusion for caesarean section: study protocol for a randomised controlled trial
por: Dell-Kuster, Salome, et al.
Publicado: (2016)

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
por: Cook, John R., et al.
Publicado: (2023)

Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines
por: Briones, Jamaica Roanne, et al.
Publicado: (2020)

A study protocol for the cardiac effects of a single dose of either oxytocin 2.5 IU or carbetocin 100 µg after caesarean delivery: a prospective randomized controlled multi-centre trial in Norway
por: Bekkenes, Maria, et al.
Publicado: (2022)

Feasibility, Acceptability, and Programme Effectiveness of Misoprostol for Prevention of Postpartum Haemorrhage in Rural Bangladesh: A Quasiexperimental Study
por: Quaiyum, Abdul, et al.
Publicado: (2014)

Carbetocin vs. Syntometrine in Prevention of Postpartum Hemorrhage: a Double Blind Randomized Control Trial
por: Samimi, Mansoureh, et al.
Publicado: (2013)

Successful prone positioning after recent caesarean section in severe ARDS with postpartum pulmonary haemorrhage
por: Phoophiboon, Vorakamol, et al.
Publicado: (2020)

Effects of a New Patient Safety-Driven Oxytocin Dosing Protocol on Postpartum Hemorrhage
por: McKenna, David S., et al.
Publicado: (2014)

Effect of Carbetocin on Postpartum Hemorrhage after Vaginal Delivery: A Meta-Analysis
por: Huang, Xiaojuan, et al.
Publicado: (2022)

The effect of carbetocin compared to misoprostol in management of the third stage of labor and prevention of postpartum hemorrhage: a systematic review
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2018)

Side‐effects of carbetocin to prevent postpartum hemorrhage: A systematic review and meta‐analysis of randomized controlled trials
por: Ai, Wen, et al.
Publicado: (2021)

Cost-effectiveness analysis of carbetocin for prevention of postpartum hemorrhage in a low-burden high-resource city of China
por: You, Joyce H. S., et al.
Publicado: (2022)

Study Protocol. ECSSIT – Elective Caesarean Section Syntocinon(® )Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon(®)) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section
por: Murphy, Deirdre J, et al.
Publicado: (2009)

Emergency Caesarean Section: Influences on the Decision-to-Delivery Interval
por: Cerbinskaite, Aiste, et al.
Publicado: (2011)

Use of Electrocautery for Coagulation and Wound Complications in Caesarean Sections
por: Moreira, Cristiane M., et al.
Publicado: (2014)

Efficacy and Safety of Carbetocin Versus Misoprostol in Cesarean Section: A Systematic Review and Meta-Analysis
por: Albazee, Ebraheem, et al.
Publicado: (2022)

Treatment of Concealed Accidental Hæmorrhage by Conservative Cæsarean Section
por: Lennie, R. A.
Publicado: (1923)

Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings
por: Carvalho, Natalie, et al.
Publicado: (2020)

Access and use of oxytocin for postpartum haemorrhage prevention: a pre-post study targeting the poorest in six Mesoamerican countries
por: Kamath, Aruna M, et al.
Publicado: (2020)

Hemodynamic Effects of Oxytocin and Carbetocin During Elective Cesarean Section in Preeclamptic Patients Under Spinal Anesthesia: A Randomized Double-blind Controlled Study
por: Bahr, Mahmoud Hussein, et al.
Publicado: (2023)

Case report: A relatively rare adverse event caused by carbetocin— placenta interception
por: Li, Jun-Qiang, et al.
Publicado: (2023)

Caesarean Section
por: Trevathan, Wenda R., et al.
Publicado: (2014)

Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial
por: Sheehan, Sharon R, et al.
Publicado: (2011)

Intraoperative cell savage for life-threatening haemorrhagic caesarean section
por: Ducloy, AS, et al.
Publicado: (2013)

Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial
por: Aawar, Nadine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6u1938lv44mc4kr8ka276hcg4s